HOME >> BIOLOGY >> NEWS
DoubleTwist completes the first annotation of the human genome

in the human genome is not trivial," said Nick Tsinoremas, Director of Research at DoubleTwist. "We have developed a computationally and scientifically intense methodology designed to provide the best overall view of the human genome, including the location of the genes and their function. This is a foundation that enables further discovery."

DoubleTwist will also license the database and associated data mining software directly to pharmaceutical and biotechnology companies for their drug discovery efforts. This software includes a Java(TM)-based, interactive data mining and visualization tool that graphically represents the annotated human genome data, facilitating rapid gene discovery. In addition, DoubleTwist provides software that enables scientists to perform text-based queries to retrieve data of interest.


'"/>

Contact: Joan Kureczka, J. Kureczka Associates
JKureczka@aol.com
415-821-2413
Kureczka/Martin Associates
7-May-2000


Page: 1 2

Related biology news :

1. OneWorld Health completes enrollment, treatment in Phase III India trial
2. Third piece completes deadly puzzle: Structure of anthrax toxin offers clues to treatment
3. TIGR completes study providing insight into infectious strain of bacterium that causes otitis, pneumonia and meningitis
4. NTP completes 500th two-year rodent study and report; series is the gold standard of animal toxicology
5. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
6. Newly identified master gene key in babys first breath
7. The book opens on the first tree genome
8. DuPont developing new protective suits for military, first responders
9. Joslin Diabetes Center adds first affiliate in California at Irvine Medical Center
10. Maine-based biophysics institute gets funding for first US-based 4Pi nanoscale microscope
11. Veterinarians discover first known case of canine distemper in a wild tiger

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: